Skip to content
New to DAT Supply? Create a client account to view pricing, order samples and start your first order.
DAT Supply Log in
Navigation
Profile

Preferences

Choose your market — it sets your site and language.

Start order

Already a member? Log in

Vitamin D3 and K2 supplements: a private-label overview

Vitamin D3 and K2 supplements: a private-label overview

Vitamin D3 and K2 are often paired in supplements to support calcium utilization and bone health. For brand owners, private-labeling this combination offers flexibility across formats like softgels, capsules, and liquid drops. This overview outlines key considerations for bringing a D3+K2 product to market through a contract manufacturer, focusing on formulation options, compliance responsibilities, and the briefing process.

What this active is and typical formats

Vitamin D3 (cholecalciferol) and vitamin K2 (menaquinone, typically MK-7) are fat-soluble vitamins commonly combined in dietary supplements. Typical formats include softgels, oil-based capsules, and liquid drops, which aid absorption. Dosages vary widely, and the combination is popular for its synergistic role in calcium metabolism.

Category fit for brand ranges

D3+K2 supplements fit well into bone health, immune support, and general wellness categories. They are often positioned alongside calcium or magnesium products, or as standalone offerings for targeted consumer segments. The combination appeals to aging populations, athletes, and those seeking preventive health support.

Formulation and format considerations

Formulation requires attention to the form of K2 (MK-7 vs. MK-4), dosage ratios, and bioavailability. Format choice affects stability and absorption; softgels and oil-based capsules are common for these fat-soluble vitamins. Excipients, fillers, and encapsulation materials must be selected to maintain potency and shelf life.

Compliance and label responsibility

Brand owners are responsible for ensuring final product labels comply with local regulations, including structure-function claims, serving sizes, and disclaimers. The manufacturer provides raw material documentation, but the brand must verify that all claims are substantiated and permissible in their target market.

How to brief this active to DAT Supply

To brief a D3+K2 product, provide target dosage per serving, preferred format (e.g., softgel, capsule), and any specific K2 form or ratio. Indicate desired capsule size or liquid volume, and any additional ingredients. DAT Supply will then propose formulations and samples under the Make it Yours model for review.

Continue exploring

Where to next?

Browse the reviewed catalogue, request samples, or start an order when you're ready — the DAT Supply portal routes your brief through the right review step.

Quick context request

Get manufacturing context

Drop your work email and a member of the DAT team will follow up with the right context for this concept. Order documents, certificates and pricing are released through the client workspace in the DAT portal.

You will receive a short confirmation email. Order documents (specification, batch-specific COA, packaging documents) are released through the client workspace in the DAT portal once a brief is in place.

/usr/bin/bash: line 5: /tmp/hermes-snap-51302552d562.sh: No such file or directory /usr/bin/bash: line 6: /tmp/hermes-cwd-51302552d562.txt: No such file or directory